From GLP-1s to Red #40: Are We Treating Obesity In Our Children or Fueling It?
GLP-1 Medications in Children: A New Frontier or a Slippery Slope? The rise of GLP-1 receptor agonists—like semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda)—has revolutionized the treatment of obesity and type 2 diabetes in adults. But...